Quantum Biopharma bought Bitcoin and other cryptocurrencies price 1 million US dollars, in response to the Canadian biotechnology company.
According to a press release on May 19, purchases take over the complete cryptocurrency stocks from Quantum to approx. 4.5 million US dollars. The biotech company plans to enter a part of its crypto to realize revenue.
Quantum assumes […] Make a certain protection against the Canadian dollar, ”it said.
The shares of Quantum, QNTM, after the announcement after announcement, rose by about 25%, in response to data from Google Finance.
Quantum Biopharma's share increased within the announcement. Source: Google Finance
Popular financial strategy
Quantum is one in all several healthcare firms that collect Bitcoin because crypto treasure edges of firms have gotten increasingly popular.
In March, the Nasdaq-cunning biopharmaceutical company Atai Life Sciences listed plans for the acquisition of Bitcoin price $ 5 million.
In a post on March 20, the founding father of Atai, Christian Angermayer, said “Bitcoin ought to be a part of an organization Ministry of Finance -especially within the biotech sector.”
In a blog post, Angermayer added that Bitcoin may help Biotech protection before inflation and remain possible within the long periods before the approval of medication.
On May 16, the Health Society Basel Medical Group, based in Singapore, announced plans to purchase Bitcoin price $ 1 billion.
A Bitcoin Ministry of Finance will support its plans for expansion in Asia through acquisitions by giving Basel “one in all the strongest balance sheets under Asian-oriented health service providers.
In contrast to Quantum, nonetheless, the shares of Basel fell considerably on the day of the announcement.
According to BitcoinTreasuries.net, Bitcoin in Bitcoin hold Bitcoin in the company treasuries.
Stable firms are today the most important institutional Bitcoin holders in response to Börsenfonds (ETFs), as the info show.
Bitcoin can “be a useful protection against growing fiscal deficits, currency depreciation and geopolitical risks for firms,” said Asset Manager Fidelity Digital Assets in a report from 2024.
